About Mast Therapeutics, Inc.

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Description
Information
We are a biopharmaceutical company focused on developing therapies for serious or life-threatening diseases. Through our acquisition of SynthRx, Inc. in 2011, we acquired our Membrane Adhesion & Sealant Technology (MAST) platform, which includes proprietary poloxamer-related data and know-how derived from over two decades of clinical, nonclinical and manufacturing experience, and we are leveraging the MAST platform to develop MST-188 for diseases and conditions characterized by microcirculatory insufficiency.

Mast Therapeutics, Inc. Alternatives

Frequently Asked Questions about Mast Therapeutics, Inc.

What is Mast Therapeutics, Inc. email format?

The widely used Mast Therapeutics, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Mast Therapeutics, Inc. customer service number?

To contact Mast Therapeutics, Inc. customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more